Compile Data Set for Download or QSAR
Report error Found 88 Enz. Inhib. hit(s) with all data for entry = 8161
TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 235381BDBM235381(US9393245, 113 | BDBM287835)
Affinity DataIC50: 0.300nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 235368BDBM235368(US9393245, 98 | US10085990, Example 98)
Affinity DataIC50: 0.300nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 235363BDBM235363(US9393245, 93 | US10085990, Example 93)
Affinity DataIC50: 0.400nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 235364BDBM235364(US9393245, 94 | US10085990, Example 94)
Affinity DataIC50: 0.400nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 235366BDBM235366(US9393245, 96 | US10085990, Example 96)
Affinity DataIC50: 0.400nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 235367BDBM235367(US9393245, 97 | US10085990, Example 97)
Affinity DataIC50: 0.600nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 235370BDBM235370(US9393245, 100 | US10085990, Example 100)
Affinity DataIC50: 0.900nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 235362BDBM235362(US9393245, 91 | US10085990, Example 91)
Affinity DataIC50: 1nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 235375BDBM235375(US9393245, 107 | US10085990, Example 107)
Affinity DataIC50: 1nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 235359BDBM235359(US9393245, 88 | US10085990, Example 88)
Affinity DataIC50: 1nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 235355BDBM235355(US9393245, 83 | US10085990, Example 83)
Affinity DataIC50: 1nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 135819BDBM135819(US8853226, 103 | US9393245, 103 | US10085990, Exam...)
Affinity DataIC50: 1nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 235350BDBM235350(US9393245, 78 | US10085990, Example 78)
Affinity DataIC50: 1nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 235365BDBM235365(US9393245, 95 | US10085990, Example 95)
Affinity DataIC50: 1nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 235361BDBM235361(US9393245, 90 | US10085990, Example 90)
Affinity DataIC50: 2nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 235358BDBM235358(US9393245, 87 | US10085990, Example 87)
Affinity DataIC50: 2nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 235390BDBM235390(US9393245, 126 | US10085990, Example 126)
Affinity DataIC50: 2nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 135817BDBM135817(US8853226, 84 | US9393245, 84 | US10085990, Exampl...)
Affinity DataIC50: 2nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 235383BDBM235383(US9393245, 116 | US10085990, Example 116)
Affinity DataIC50: 2nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 135818BDBM135818(US8853226, 92 | US9393245, 92 | US10085990, Exampl...)
Affinity DataIC50: 2.40nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 235374BDBM235374(US9393245, 106 | US10085990, Example 106)
Affinity DataIC50: 4nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 235344BDBM235344(US9393245, 72 | US10085990, Example 72)
Affinity DataIC50: 4nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 235360BDBM235360(US9393245, 89 | US10085990, Example 89)
Affinity DataIC50: 5nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 135824BDBM135824(US8853226, 127 | US9393245, 127 | US10085990, Exam...)
Affinity DataIC50: 6nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 235347BDBM235347(US9393245, 75 | US10085990, Example 75)
Affinity DataIC50: 6nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 135816BDBM135816(US8853226, 54 | US9393245, 54 | US10085990, Exampl...)
Affinity DataIC50: 6nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 235377BDBM235377(US9393245, 109 | US10085990, Example 109)
Affinity DataIC50: 8nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 235345BDBM235345(US9393245, 73 | US10085990, Example 73)
Affinity DataIC50: 9nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

LigandChemical structure of BindingDB Monomer ID 135819BDBM135819(US8853226, 103 | US9393245, 103 | US10085990, Exam...)
Affinity DataIC50: 17nMT: 2°CAssay Description:The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 235369BDBM235369(US9393245, 99 | US10085990, Example 99)
Affinity DataIC50: 20nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

LigandChemical structure of BindingDB Monomer ID 135824BDBM135824(US8853226, 127 | US9393245, 127 | US10085990, Exam...)
Affinity DataIC50: 25nMT: 2°CAssay Description:The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

LigandChemical structure of BindingDB Monomer ID 135822BDBM135822(US8853226, 121 | US9393245, 121 | US10085990, Exam...)
Affinity DataIC50: 26nMT: 2°CAssay Description:The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 135821BDBM135821(US8853226, 118 | US9393245, 118 | US10085990, Exam...)
Affinity DataIC50: 29nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 135820BDBM135820(US8853226, 115 | US9393245, 115 | US10085990, Exam...)
Affinity DataIC50: 29nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 135815BDBM135815(US8853226, 51 | US9393245, 51 | US10085990, Exampl...)
Affinity DataIC50: 30nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 235382BDBM235382(US9393245, 114 | US10085990, Example 114)
Affinity DataIC50: 31nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

LigandChemical structure of BindingDB Monomer ID 135823BDBM135823(US8853226, 122 | US9393245, 122 | US10085990, Exam...)
Affinity DataIC50: 39nMT: 2°CAssay Description:The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

LigandChemical structure of BindingDB Monomer ID 135820BDBM135820(US8853226, 115 | US9393245, 115 | US10085990, Exam...)
Affinity DataIC50: 49nMT: 2°CAssay Description:The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

LigandChemical structure of BindingDB Monomer ID 135819BDBM135819(US8853226, 103 | US9393245, 103 | US10085990, Exam...)
Affinity DataIC50: 55nMT: 2°CAssay Description:The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

LigandChemical structure of BindingDB Monomer ID 135822BDBM135822(US8853226, 121 | US9393245, 121 | US10085990, Exam...)
Affinity DataIC50: 59nMT: 2°CAssay Description:The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

LigandChemical structure of BindingDB Monomer ID 135818BDBM135818(US8853226, 92 | US9393245, 92 | US10085990, Exampl...)
Affinity DataIC50: 68nMT: 2°CAssay Description:The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

LigandChemical structure of BindingDB Monomer ID 135824BDBM135824(US8853226, 127 | US9393245, 127 | US10085990, Exam...)
Affinity DataIC50: 73nMT: 2°CAssay Description:The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 235379BDBM235379(US9393245, 111 | US10085990, Example 111)
Affinity DataIC50: 74nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

LigandChemical structure of BindingDB Monomer ID 135816BDBM135816(US8853226, 54 | US9393245, 54 | US10085990, Exampl...)
Affinity DataIC50: 78nMT: 2°CAssay Description:The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

LigandChemical structure of BindingDB Monomer ID 135823BDBM135823(US8853226, 122 | US9393245, 122 | US10085990, Exam...)
Affinity DataIC50: 80nMT: 2°CAssay Description:The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

LigandChemical structure of BindingDB Monomer ID 135821BDBM135821(US8853226, 118 | US9393245, 118 | US10085990, Exam...)
Affinity DataIC50: 80nMT: 2°CAssay Description:The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Vtv Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 235378BDBM235378(US9393245, 110 | US10085990, Example 110)
Affinity DataIC50: 123nMT: 2°CAssay Description:Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at ro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

LigandChemical structure of BindingDB Monomer ID 135815BDBM135815(US8853226, 51 | US9393245, 51 | US10085990, Exampl...)
Affinity DataIC50: 126nMT: 2°CAssay Description:The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

LigandChemical structure of BindingDB Monomer ID 135818BDBM135818(US8853226, 92 | US9393245, 92 | US10085990, Exampl...)
Affinity DataIC50: 151nMT: 2°CAssay Description:The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

LigandChemical structure of BindingDB Monomer ID 135820BDBM135820(US8853226, 115 | US9393245, 115 | US10085990, Exam...)
Affinity DataIC50: 163nMT: 2°CAssay Description:The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2017
Entry Details
US Patent

Displayed 1 to 50 (of 88 total ) | Next | Last >>
Jump to: